低温等离子射频消融术治疗喉部恶性肿瘤的临床疗效  

The efficacy of transoral coblation microsurgery for laryngocarcinoma

作　　者：李为民[1] 王荣光[1] 黄冬雁[1] 刘小丽[1] 金伟[1] 杨仕明[1] 

机构地区：[1]解放军总医院耳鼻咽喉-头颈外科解放军耳鼻咽喉研究所,北京100853

出　　处：《中国老年学杂志》2015年第6期1449-1451,共3页Chinese Journal of Gerontology

基　　金：国家973项目资助(2012CB967900);解放军总医院科研扶持基金资助(2012FC ZHCG 1007)

摘　　要：目的探讨经口低温等离子辅助显微外科(TCM)治疗喉癌的效果。方法回顾性分析2008年10月至2013年5月解放军总医院耳鼻咽喉头颈外科143例TCM治疗喉癌的手术资料。结果 143例均达到内窥镜全切除标准,其中75例术前有病理结果,28例行术中冰冻病理切片检查,40例未行术前或术中病理检查,仅有术后病理检查。中位随访时间24.5个月(5~60个月)。术后复发8例,再次行TCM治疗4例,4例行喉裂开声带切除或喉部分切除术,死亡3例。结论 TCM可作为喉癌微创手术方法之一,具有很好的临床应用价值。Objective To investigate the initial efficacy of transoral coblation microsurgery( TCM) for laryngocarcinoma. Methods A total of 143 patients treated with TCM were retrospectively reviewed. Among them,72 patients were with stage T1 laryngeal cancers,47 with T2,20 with T3 and 4 with T4. The study population consisted of 128 males and 15 females,aged 35 ~ 90 years old,mean age of( 53. 45 ±16. 46) years. Results Total 143 resection was achieved endoscopically in all the patients. Among them,75 patients had pathologic diagnosis in preoperative,28 ones had frozen pathological diagnosis intraoperative and 40 patients had only pathologic diagnosis after operative. All patients were followed up 5 ~ 60 months( median,24. 5 months),8 patients had suffered local recurrence,4 patients were accepted TCM a second time,4 patients were accepted partial laryngectomy,3 patients had dead. Conclusions TCM is a safe and effective treatment alternative for selected each periods malignant neoplasms at stage T1-T4.

关 键 词：经口低温等离子辅助显微外科 低温等离子射频消融术 喉癌 

分 类 号：R739.65[医药卫生—肿瘤]